Acute myeloid leukemia with minimal differentiation
MONDO:0005223An acute myeloid leukemia (AML) in which the blasts do not show evidence of myeloid differentiation by morphology and conventional cytochemistry. (WHO, 2001)
Also known as: AML M0, AML with minimal differentiation, M0 acute granulocytic leukaemia, M0 acute granulocytic leukaemia with minimal differentiation, M0 acute granulocytic leukemia, M0 acute granulocytic leukemia with minimal differentiation, M0 acute myeloblastic leukaemia, M0 acute myeloblastic leukemia
3091 clinical trials for this condition and its sub-types, 2 tagged with Acute myeloid leukemia with minimal differentiation itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Can a Platelet-Boosting drug speed recovery for older leukemia patients?
Disease control CompletedThis phase II trial investigates whether eltrombopag, a drug that stimulates platelet production, can help older adults with acute myeloid leukemia (AML) recover their platelet counts faster after initial chemotherapy. Older patients often experience slow platelet recovery, which…
Phase 2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Could a targeted drug keep AML in check?
Disease control CompletedThis phase III trial tests whether the drug tipifarnib can prevent acute myeloid leukemia (AML) from coming back in patients who are already in remission. Participants include adults over 60 in first remission, those in second or later remission, or those who achieved remission a…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC